281 results match your criteria: "George Washington University Biostatistics Center[Affiliation]"
Am J Perinatol
August 2006
George Washington University Biostatistics Center, Rockville, Maryland 20852, USA.
The purpose was to assess practicing obstetrician-gynecologists' knowledge about the prenatal diagnosis and postnatal prognosis of spina bifida. Written questionnaires designed to assess practicing obstetrician-gynecologists' knowledge of spina bifida were mailed to 1000 randomly selected American College of Obstetricians and Gynecologists Fellows. More than 50% did not identify many of the sonographic features indicative of an open neural tube defect in the fetus and more than one third overestimated the risks of stillbirth, whereas more than two thirds overestimated the risk for premature delivery in a pregnancy complicated by fetal spina bifida.
View Article and Find Full Text PDFDiabetes Care
February 2006
George Washington University Biostatistics Center, 6110 Executive Blvd., Suite 750, Rockville, MD 20852, USA.
Objective: The study was conducted in 12 middle schools to determine the prevalence of diabetes, pre-diabetes, and diabetes risk factors in eighth-grade students who were predominantly minority and evaluate the feasibility of collecting physical and laboratory data in schools.
Research Design And Methods: Anthropometric measurements and fasting and 2-h post-glucose load blood draws were obtained from approximately 1,740 eighth-grade students.
Results: Mean recruitment rate was 50% per school, 49% had BMI > or = 85th percentile, 40.
The Diabetes Prevention Program (DPP) was a randomized clinical trial of prevention of type 2 diabetes in high-risk people. Troglitazone, an insulin-sensitizing agent, was used initially but was discontinued during the trial. Troglitazone therapy was compared with other DPP interventions, considering both the short-term "in-trial" results and the longer-term results after troglitazone were discontinued.
View Article and Find Full Text PDFAnn Epidemiol
November 2004
The Diabetes Prevention Program Coordinating Center, George Washington University Biostatistics Center, Rockville, MD 20852, USA.
Purpose: To describe usual dietary intake assessment at baseline and 1-year post-randomization in the ethnically diverse Diabetes Prevention Program cohort.
Methods: Participants were randomized to Lifestyle Modification, Metformin, or Placebo. Usual diet was assessed by a modified, previously validated food frequency interview.
Ann N Y Acad Sci
June 1998
Administration on Children, Youth and Families (ACYF), Box 1182-Children's Bureau, Washington, DC 20013. Phone, 202/205-8172; fax, 202/401-5917; e-mail, National Institute on Child Health and Human Development (NICHD), 6100 Executive Blvd., Room 4B03G, Rockville, MD 20852. Phone, 301/496-5575; fax, 301/496-3790; e-mail, University of Miami School of Medicine, Jackson Memorial Hospital, Department of Pediatrics, Maternal Lifestyles Study, Dominion Towers, Room 813, 1400 NW 10th Avenue, Miami, FL. 33136. Phone, 303/243-4841; fax, 305/243-6032; e-mail, Wayne State University School of Medicine, Children's Hospital of Michigan, Division of Neonatal and Perinatal Medicine, 3901 Beaubian Boulevard, Room 401, Detroit, MI 48201. Phone, 313/745-1436; fax, 313/745-5867; e-mail, University of Tennessee School of Medicine, E.H. Crump Hospital, New Born Center 853 Jefferson Avenue, Room 201, Memphis, TN 38163. Phone, 901/448-5950; fax, 901/448-1691; e-mail, Brown University, Women's and Infants Hospital, Department of Pediatrics, 101 Dudley Street, Providence, RI 02905. Phone, 401/453-7640/41; fax, 401/453-7646; e-mail, Washington University Biostatistics Center, 6110 Executive Blvd., Suite 750, Rockville, MD 20852. Phone, 301/881-9260; fax, 301/816-0385 National Institute on Drug Abuse (NIDA), Clinical Medicine Branch, 5600 Fishers Lane, Room 10A-08, Rockville, MD 20857. Phone, 301/443-1801 9; fax, 301/594-6566; e-mail, George Washington University Biostatistics Center, 6110 Executive Blvd., Suite 750, Rockville, MD 20852. Phone, 301/881-9260; fax, 301/816-0385; e-mail,
Diabetes
April 1997
George Washington University Biostatistics Center, Rockville, Maryland 20852, USA.
Risk factors associated with the progression from impaired glucose tolerance (IGT) to NIDDM were examined in data from six prospective studies. IGT and NIDDM were defined in all studies by World Health Organization (WHO) criteria, and baseline risk factors were measured at the time of first recognition of IGT. The studies varied in size from 177 to 693 participants with IGT, and included men and women followed from 2 to 27 years after the recognition of IGT.
View Article and Find Full Text PDF